Concepedia

Karen McGovern

KM

Statistics

Publications

32

Citations

8.7K

H-Index

24

Active since

1991

Affiliations

Infinity Pharmaceuticals (United States)(Current)

Harvard University

Hospital for Sick Children

Mount Sinai Hospital

Cleveland Clinic

Karen McGovern is an author at Infinity Pharmaceuticals (United States) specializing in oncology, life sciences, and pharmacology.

Publications per year

1991–2023

32

Publications

32

Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer

Kenneth P. Olive, Michael A. Jacobetz, Christian J. Davidson et al. · Science · 2009 · 3.1K citations · Full text

Medicine, Oncology, Pharmacology +17

PI3Kγ is a molecular switch that controls immune suppression

Megan M. Kaneda, Karen Messer, Natacha Ralainirina et al. · Nature · 2016 · 1.2K citations

Life Sciences, Immunology, Molecular Biology +14

Identification of a protein required for disulfide bond formation in vivo

James C.A. Bardwell, Karen McGovern, J Beckwith · Cell · 1991 · 987 citations

Life Sciences, Biochemistry, Molecular Biology +12

Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells

Olivier De Henau, Matthew Rausch, David A. Winkler et al. · Nature · 2016 · 865 citations

Medicine, Cancer Biology, Oncology +14

Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine

Luís Felipe Campesato, Sadna Budhu, Jeremy H. Tchaicha et al. · Nature Communications · 2020 · 466 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 32